-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Sonoma Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
- Sonoma Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2024 was $9K.
- Sonoma Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2024 was $10K.
- Sonoma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was -$196K, a 494% decline from 2022.
- Sonoma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was -$33K, a 90.1% increase from 2021.
- Sonoma Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was -$332K, a 147% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)